Geoff Birkett
2022
In 2022, Geoff Birkett earned a total compensation of $367K as Chief Commercial Officer at Ensysce Biosciences, a 172% increase compared to previous year.
Compensation breakdown
| Option Awards | $53,664 |
|---|---|
| Salary | $304,167 |
| Other | $9,125 |
| Total | $366,956 |
Birkett received $304.2K in salary, accounting for 83% of the total pay in 2022.
Birkett also received $53.7K in option awards and $9.1K in other compensation.
Rankings
In 2022, Geoff Birkett's compensation ranked 4,841st out of 5,760 executives tracked by ExecPay. In other words, Birkett earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,841 out of 5,760 | 16th |
Division Manufacturing | 2,685 out of 3,136 | 14th |
Major group Chemicals And Allied Products | 1,265 out of 1,422 | 11th |
Industry group Drugs | 1,190 out of 1,323 | 10th |
Industry Pharmaceutical Preparations | 872 out of 969 | 10th |
Source: SEC filing on July 13, 2023.
Birkett's colleagues
We found three more compensation records of executives who worked with Geoff Birkett at Ensysce Biosciences in 2022.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021